Publikationen von Fabian Coscia

Santos, A.; Colaco, A. R.; Nielsen, A. B.; Niu, L.; Strauss, M.; Geyer, P. E.; Coscia, F.; Albrechtsen, N. J. W.; Mundt, F.; Jensen, L. J. et al.; Mann, M.: A knowledge graph to interpret clinical proteomics data. Nature Biotechnology 40, S. 692 - 702 (2022)

Coscia, F.; Doll, S.; Bech, J. M.; Schweizer, L.; Mund, A.; Lengyel, E.; Lindebjerg, J.; Madsen, G. I.; Moreira, J. M. A.; Mann, M.: A streamlined mass spectrometry-based proteomics workflow for large-scale FFPE tissue analysis. JOURNAL OF PATHOLOGY 251 (1), S. 100 - 112 (2020)

Eckert, M. A.; Coscia, F.; Chryplewicz, A.; Chang, J. W.; Hernandez, K. M.; Pan, S.; Tienda, S. M.; Nahotko, D. A.; Li, G.; Blazenovic, I. et al.; Lastra, R. R.; Curtis, M.; Yamada, S. D.; Perets, R.; McGregor, S. M.; Andrade, J.; Fiehn, O.; Moellering, R. E.; Mann, M.; Lengyel, E.: Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature 569 (7758), S. 723 - 728 (2019)

Hart, P. C.; Kenny, H. A.; Grassl, N.; Walters, K. M.; Litchfield, L. M.; Coscia, F.; Blazenovic, I.; Ploetzky, L.; Fiehn, O.; Mann, M. et al.; Lengyel, E.; Romero, I. L.: Mesothelial Cell HIF1 alpha Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk. CELL REPORTS 29 (12), S. 4086 - 4098.e6 (2019)

Coscia, F.; Lengyel, E.; Duraiswamy, J.; Ashcroft, B.; Bassani-Sternberg, M.; Wierer, M.; Johnson, A.; Wroblewski, K.; Montag, A.; Yamada, S. D. et al.; Lopez-Mendez, B.; Nilsson, J.; Mund, A.; Mann, M.; Curtis, M.: Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer. Cell 175 (1), S. 159 - 170.e16 (2018)

Doll, S.; Kriegmair, M. C.; Santos, A.; Wierer, M.; Coscia, F.; Neil, H. M.; Porubsky, S.; Geyer, P. E.; Mund, A.; Nuhn, P. et al.; Mann, M.: Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient. Molecular Oncology 12 (8), S. 1296 - 1307 (2018)

Coscia, F.; Watters, K. M.; Curtis, M.; Eckert, M. A.; Chiang, C. Y.; Tyanova, S.; Montag, A.; Lastra, R. R.; Lengyel, E.; Mann, M.: Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status. Nature Communications 7, 12645 (2016)

Coscia, F.; Lengyel, E.; Duraiswamy, J.; Ashcroft, B.; Bassani-Sternberg, M.; Wierer, M.; Johnson, A.; Wroblewski, K.; Montag, A.; Yamada, S. D. et al.; Mann, M.; Curtis, M.: Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer. In Clinical Cancer Research, 24 (15), S. 95 - 95. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, 01. Oktober 2017 - 04. Oktober 2017. Association for Cancer Research, Denville, NJ (2018)

Eckert, M. A.; Coscia, F.; Chryplewicz, A.; Chang, J. W.; Pan, S.; Tienda, S. M.; Lastra, R. R.; Curtis, M.; Yamada, S. D.; McGregor, S. M. et al.; Moellering, R. E.; Mann, M.; Lengyel, E.: Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment. In Clinical Cancer Research, 24 (15), S. 52 - 53. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, 01. Oktober 2017 - 04. Oktober 2017. Association for Cancer Research, Denville, NJ (2018)

Eckert, M. A.; Coscia, F.; Chryplewicz, A.; Chang, J. W.; Pan, S.; Tienda, S. M.; Lastra, R. R.; Curtis, M.; Yamada, S. D.; McGregor, S. M. et al.; Moellering, R. E.; Mann, M.; Lengyel, E.: Nicotinamide N-methyltransferase metabolically reprograms the stroma to promote ovarian cancer metastasis. In Clinical Cancer Research, 24 (15), S. 30 - 30. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, 01. Oktober 2017 - 04. Oktober 2017. Association for Cancer Research, Denville, NJ (2018)

Mukherjee, A.; Coscia, F.; Fahrmann, J.; Chiang, C.-Y.; Smith, J.; Nieman, K.; Ladanyi, A.; Romero, I.; Fiehn, O.; Mann, M. et al.; Lengyel, E.: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis. In Clinical Cancer Research, 24 (15), S. 45 - 45. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, 01. Oktober 2017 - 04. Oktober 2017. Association for Cancer Research, Denville, NJ (2018)

Coscia, F.: Ovarian Cancer Proteomics. Dissertation, Ludwig-Maximilians-Universität, München (2016)